NewsDesk @bactiman63 Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant has been dosed in a Phase 1 trial of...

NewsDesk @bactiman63 Cambridge, Massachusetts company, Public Health Vaccines, LLC announced today the start of its Phase 1 clinical trial to evaluate the safety and immunogenicity of the company’s...

A vaccine for use against the deadly Nipah and Hendra viruses has demonstrated effectiveness in preclinical studies as early as 7 days following a single immunization, according to a new study, “A...

Biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Moderna, announced today  that it is expanding its pipeline of innovative vaccines with three new development programs...

Nipah virus is a type of RNA virus transmitted from animals to humans. The infection causes severe respiratory illness and symptoms including cough, headache and fever, which can progress into encephalitis,...